Stephen Kolb
Director, ALS/MND Multidisciplinary Clinic and Translational Research Program · Ohio State University Hospital
Credentials: · · · · ·
History
PresentOhio State University Hospital · The Ohio State University Wexner Medical Center
- 1998–1999
Graduate School of Biomedical Sciences at UTHSC
Research
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene
Neuron · 2018 · 571 citations
Review · Neurologic Clinics · 2015 · First of 2 authors · Corresponding · 439 citations
Natural history of infantile-onset spinal muscular atrophy
Annals of Neurology · 2017 · First of 38 authors · 331 citations
27 papers · 4 as a resident
- JK
20 papers
13 papers
11 papers
10 papers
- BD
8 papers
- KK
7 papers
7 papers
Grants
- 2018–2024
Network for Excellence in Neuroscience Clinical Trials Center at The Ohio State University
National Institute of Neurological Disorders and Stroke · U24
Contact PI · $1.6M · Ohio State University
- 2020–2022
Characterization of a Mouse Model of KIF5A-Associated ALS
National Institute of Neurological Disorders and Stroke · R03
Contact PI · $156K · Ohio State University
- 2017–2022
Survival Motor Neuron (SMN) Function in Motoneuron Development
National Institute of Neurological Disorders and Stroke · R01
PI · $1.1M · Ohio State University
- 2012–2017
SMA Biomarkers in the Immediate Post-Natal Period of Development
National Institute of Neurological Disorders and Stroke · U01
Contact PI · $2.1M · Ohio State University
Clinical trials
- 2012–2015
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Principal investigator · Completed
Ohio State University
- 2024–2029